Literature DB >> 7037817

Effect of domperidone, an extracerebral inhibitor of dopamine receptors, on thyrotropin, prolactin, renin, aldosterone, and 18-hydroxycorticosterone secretion in man.

J R Sowers, B Sharp, R W McCallum.   

Abstract

This study investigates the dopaminergic mechanisms involved in the control of corticosteroid secretion in normal subjects. TSH, PRL, PRA, aldosterone, and 18-hydroxycorticosterone (18-OHB) were measured before and after the administration of domperidone (10 mg, iv) to eight healthy males. Domperidone, a selective peripheral dopamine antagonist, stimulated TSH and PRL secretion. Plasma concentrations of aldosterone, 18-OHB, cortisol, and PRA were not altered by domperidone. This is in contrast to previous observations of aldosterone, 18-OHB, and PRA responses to metoclopramide, a dopamine antagonist which readily crosses the blood-brain barrier. Domperidone may fail to stimulate aldosterone, 18-OHB, and renin secretion because it does not cross the blood-brain barrier or does not function as an antagonist for adrenal dopamine receptors modulating 18-OHB and aldosterone secretion.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7037817     DOI: 10.1210/jcem-54-4-869

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

Review 1.  Clinical pharmacokinetics of tegaserod, a serotonin 5-HT(4) receptor partial agonist with promotile activity.

Authors:  Silke Appel-Dingemanse
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 2.  Neuroendocrine causes of amenorrhea--an update.

Authors:  Lindsay T Fourman; Pouneh K Fazeli
Journal:  J Clin Endocrinol Metab       Date:  2015-01-12       Impact factor: 5.958

3.  Domperidone treatment in man inhibits the fall in plasma renin activity induced by intravenous gamma-L-glutamyl-L-dopa.

Authors:  D P Worth; J N Harvey; J Brown; A Worral; M R Lee
Journal:  Br J Clin Pharmacol       Date:  1986-05       Impact factor: 4.335

Review 4.  Prokinetics in diabetic gastroparesis.

Authors:  Reza A Hejazi; Richard W McCallum; Irene Sarosiek
Journal:  Curr Gastroenterol Rep       Date:  2012-08

5.  Cholinergic independent dopaminergic regulation of motilin release in man.

Authors:  A Funakoshi; M Matsumoto; K Sekiya; I Nakano; H Shinozaki; H Ibayashi
Journal:  Gastroenterol Jpn       Date:  1983-12

6.  Effects of acute administration of zetidoline, a new antidopaminergic drug, on plasma prolactin and aldosterone levels in man.

Authors:  C Barbieri; M Parodi; S Bruno; F Bertassi; D Benaglia; P Moser; R Meroni; A Dubini
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

7.  Increased serum prolactin but normal TSH during prolonged domperidone treatment in children.

Authors:  A R Deprettere; K J Van Acker; M V Du Caju
Journal:  Eur J Pediatr       Date:  1987-03       Impact factor: 3.183

Review 8.  Metoclopramide. An updated review of its pharmacological properties and clinical use.

Authors:  R A Harrington; C W Hamilton; R N Brogden; J A Linkewich; J A Romankiewicz; R C Heel
Journal:  Drugs       Date:  1983-05       Impact factor: 9.546

Review 9.  Domperidone. A review of its pharmacological activity, pharmacokinetics and therapeutic efficacy in the symptomatic treatment of chronic dyspepsia and as an antiemetic.

Authors:  R N Brogden; A A Carmine; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-11       Impact factor: 9.546

10.  Pharmacological causes of hyperprolactinemia.

Authors:  Daria La Torre; Alberto Falorni
Journal:  Ther Clin Risk Manag       Date:  2007-10       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.